Provided by Tiger Trade Technology Pte. Ltd.

Cytokinetics

76.84
-0.3400-0.44%
Post-market: 76.880.0400+0.05%19:30 EDT
Volume:1.52M
Turnover:117.29M
Market Cap:10.68B
PE:-10.70
High:77.70
Open:77.30
Low:76.65
Close:77.18
52wk High:88.31
52wk Low:35.22
Shares:139.02M
Float Shares:138.02M
Volume Ratio:0.94
T/O Rate:1.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.1827
EPS(LYR):-6.5400
ROE:-572.15%
ROA:-28.09%
PB:-61.58
PE(LYR):-11.75

Loading ...

Cytokinetics to Announce Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy, on May 5, 2026

GlobeNewswire
·
May 05

Western Union, Cytokinetics, Comfort Systems, Albertsons, ASE Shocker

TIPRANKS
·
May 02

Cytokinetics call volume above normal and directionally bullish

TIPRANKS
·
May 02

Top Cytokinetics Executive Makes Major Move With Insider Stock Sale

TIPRANKS
·
May 01

Cytokinetics EVP, Chief Commercial Officer Andrew Callos disposes 15,000 shares for $948,900

Reuters
·
May 01

Cytokinetics CEO Robert I. Blum sells 7,500 shares for $447,150

Reuters
·
Apr 30

Earning Preview: Cytokinetics Q1 revenue is expected to increase by 616.29%, and institutional views are bullish

Earnings Agent
·
Apr 28

Cytokinetics to present MAPLE-HCM aficamten data at ESC Heart Failure Congress

Reuters
·
Apr 28

Cytokinetics Announces Nine Upcoming Presentations at the European Society of Cardiology Heart Failure 2026 Congress

THOMSON REUTERS
·
Apr 28

Insider Shake-Up at TransDigm, Cytokinetics, ASE, Alexandria, Itau

TIPRANKS
·
Apr 25

Edgewise Therapeutics Faces Near-Term Upside From Cytokinetics' Upcoming Readout, RBC Says

MT Newswires Live
·
Apr 25

Analysts Have Conflicting Sentiments on These Healthcare Companies: Elevance Health (ELV), Medpace Holdings (MEDP) and Cytokinetics (CYTK)

TIPRANKS
·
Apr 23

Bank of America Securities Keeps Their Hold Rating on Cytokinetics (CYTK)

TIPRANKS
·
Apr 22

Top Cytokinetics Executive Makes Notable Move With Fresh Stock Sale

TIPRANKS
·
Apr 22

Cytokinetics EVP R&D Malik Fady Ibraham sells 3,500 shares for $229,915

Reuters
·
Apr 22

Cytokinetics to Announce First Quarter Results on May 5, 2026

GlobeNewswire
·
Apr 22

Cytokinetics grants inducement equity awards to 33 new employees

Reuters
·
Apr 21